0001723128-19-000073.txt : 20190508 0001723128-19-000073.hdr.sgml : 20190508 20190508174939 ACCESSION NUMBER: 0001723128-19-000073 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20190506 FILED AS OF DATE: 20190508 DATE AS OF CHANGE: 20190508 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Patel Gautam CENTRAL INDEX KEY: 0001738054 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38485 FILM NUMBER: 19808052 MAIL ADDRESS: STREET 1: C/O AMNEAL PHARMACEUTICALS LLC STREET 2: 400 CROSSING BLVD CITY: BRIDGEWATER STATE: NJ ZIP: 08807 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Amneal Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001723128 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: BUSINESS PHONE: (908) 947-3120 MAIL ADDRESS: STREET 1: 400 CROSSING BOULEVARD STREET 2: 3RD FLOOR CITY: BRIDGEWATER STATE: NJ ZIP: 08807 FORMER COMPANY: FORMER CONFORMED NAME: Atlas Holdings, Inc. DATE OF NAME CHANGE: 20171117 4 1 wf-form4_155735216396679.xml FORM 4 X0306 4 2019-05-06 0 0001723128 Amneal Pharmaceuticals, Inc. AMRX 0001738054 Patel Gautam C/O CEPHEID CAPITAL, LLC 277 W. 4TH STREET, UNIT 2 NEW YORK NY 10014 1 0 1 0 Class A Common Stock 2019-05-08 4 M 0 6107 A 6107 D Stock Option 14.05 2019-05-06 4 A 0 28044 0 A 2029-05-06 Class A Common Stock 28044.0 28044 D Restricted Stock Units 2019-05-06 4 A 0 6459 0 A Class A Common Stock 6459.0 6459 D Restricted Stock Units 2019-05-08 4 M 0 6107 0 D Class A Common Stock 6107.0 0 D Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. The option vests on the later of (i) the day immediately preceeding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant. Restricted stock units vest on the later of (i) the day immediately preceeding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant. The restricted stock units do not expire. On May 7, 2018, the reporting person was granted 6,107 restricted stock units vesting on May 8, 2019. Exhibit 24 - Power of Attorney /s/ Brian P. Spitser, Attorney-in-Fact 2019-05-08 EX-24 2 patelgautamsection16powero1.htm PATEL GAUTAM POWER OF ATTORNEY Exhibit

POWER OF ATTORNEY
Know all by these presents, that the undersigned hereby constitutes and appoints each of (i) the Chief Legal Officer of Amneal Pharmaceuticals, Inc., a Delaware corporation (the “Company”) and who is currently David A. Buchen, (ii) the Company's Chief Financial Officer, who is currently Todd P. Branning, (iii) the Company’s Assistant Secretary, who is currently Brian P. Spitser, and (iv) the Company’s Chief Human Resources Officer, who is currently Nikita Shah, and their respective successors (including anyone serving in such capacities on an interim or acting basis), signing singly, with full powers of substitution, as the undersigned’s true and lawful attorney-in-fact to:
1.
prepare, execute in the undersigned’s name and on the undersigned’s behalf, and submit to the U.S. Securities and Exchange Commission (the “SEC”) a Form ID, including amendments thereto, and any other documents necessary or appropriate to obtain codes and passwords enabling the undersigned to make electronic filings with the SEC of reports required by Section 16(a) of the Securities Exchange Act of 1934 or any rule or regulation of the SEC;
2.
execute for and on behalf of the undersigned, in the undersigned’s capacity as an officer and/or director of the Company, and/or 10% holder of the Company’s capital stock, Forms 3, 4, and 5 and any amendments thereto in accordance with Section 16(a) of the Securities Exchange Act of 1934 and the rules thereunder;
3.
do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4, or 5, complete and execute any amendment or amendments thereto, and timely file such form with the SEC and any stock exchange or similar authority; and
4.
take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact’s discretion.
The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact’s substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned’s responsibilities to comply with Section 16 of the Securities Exchange Act of 1934.
This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4, and 5 with respect to the undersigned’s holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to
be executed as of this 20th day of February, 2019.

/s/ Gautam Patel                
By: Gautam Patel